Express Scripts 2013 Annual Report Download - page 3

3Express Scripts 2013 Annual Report
At Express Scripts, we pride ourselves on our history of
delivering solid fi nancial and operational performance.
While 2013 was no different in that respect, it was
signifi cantly different in many other ways.
Over the past 28 years, we have built Express Scripts
with a purpose. As we added capabilities and knowledge,
we did so with the understanding that the future of
healthcare would become even more complex. Our
focus was never on simply making our company bigger.
We set out to be better.
As a CEO, you don’t often get the opportunity to put
the leading companies in your industry side by side
and take the best of both to create a new entity. But
that was exactly what we focused on the past few years
and, as a result, Express Scripts has never been better
positioned to deliver on what our clients need most.
We brought together the best people, processes and
solutions from two extraordinary companies to build
an industry leader that processes more than a billion
prescriptions, provides the pharmacy benefi t for tens
of millions of people, and partners with thousands of
clients to control costs.
The effort from our 30,000 employees in 2013
was heroic. The result of their work is nothing short
of historic.
Even with the challenges that come with building a
common culture, a single platform and a new value
proposition, we delivered strong fi nancial performance
in 2013, and further established a solid foundation for
continued growth. In a busy year, I am most proud of
the fact that none of us ever lost sight of why we come
to work each day: to help patients get the medications
they need.
After the hard, necessary work to combine Medco
and Express Scripts, we pivot to a renewed focus
on operational excellence and organic growth. Now
with one technology platform, offering the industry’s
broadest and deepest set of solutions to all clients,
we can do more than anyone else to make the use of
prescription drugs safer and more affordable.
Our business model of alignment has never been more
important than it is now, and clients need our help
now more than ever. When we succeed in our mission,
many people win — patients, clients and shareholders.
Quite simply, we make money when we save money for
our clients.
We offer a unique value proposition — Better Decisions,
Healthier OutcomesSM — supported by Health Decision
ScienceSM, which combines behavioral sciences,
actionable data and clinical specialization to address
the biggest area of waste in healthcare: the suboptimal
decision-making that costs the United States more
than $300 billion each year. Only Express Scripts has
the insight to predict which members will make poor
health decisions, intervene appropriately and provide
specialized pharmacy care. And only we have the size,
scale and scope to drive the signifi cant changes in
healthcare our country needs.
The pharmacy benefi t must remain affordable for those
who offer it and those who use it. That drives us to
launch initiatives such as our 2014 National Preferred
Formulary. By removing just 1 percent of drugs from
our formulary and managing the change that impacted
just 2.6 percent of members, we drove 3 percent cost
savings, on average, for our clients. In 2014 alone, our
clients will reap savings of more than $700 million. We
continue to evaluate formulary management as a lever
and look for more opportunities to ensure patients are
on the right medications, from a clinical and cost-
effectiveness perspective.
In 2013, we enhanced our specialty pharmacy offering,
moving to the Accredo brand name and platform. Our
specialty pharmacy is unrivaled in its ability to deliver
high-quality, high-touch care to patients with complex,
chronic diseases. The majority of our clients exclusively
use the Accredo specialty pharmacy to manage the
TO OUR STOCKHOLDERS